Skip to main content
ILMN logo

ILMN · Illumina, Inc.

Track ILMN — free
$190.89 -1.75 (-0.91%) At close · Aug 14
Market Cap
$28.82B
Shares
151.00M

Illumina, Inc. Earnings Call Transcripts

Every quarterly earnings call for Illumina, Inc. (ILMN) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.

Earnings call
FY27 · Q2
2026-07-30
Q2 2026 Illumina, Inc. Earnings Conference Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY27 · Q1
2026-07-30
Illumina, Inc. Q4 FY2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q4
2026-02-05
Illumina, Inc. Q3 FY2026 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY26 · Q2
2025-10-30
Illumina, Inc. Q2 FY2026 Earnings Call
Revenue
$1.16B
▲ 9.4% YoY
Diluted EPS
$1.35
▼ 9.4% YoY
Gross margin
66.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2025-07-31
Illumina, Inc. Q1 FY2026 Earnings Call
Confident tone Clinical / Sequencing Consumables Growth NovaSeq X Platform Momentum Spatial Competition (10x Genomics)
Revenue
$1.09B
▲ 4.8% YoY
Diluted EPS
$0.87
▲ 6.1% YoY
Gross margin
66.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-02-06
Illumina, Inc. Q4 FY2025 Earnings Call
Confident tone China / Greater China Multiomics & Somalogic Research Market / Funding
Revenue
$1.16B*
▲ 5% YoY
Gross margin
65.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2024-11-04
Illumina, Inc. Q3 FY2025 Earnings Call
Positive tone China & Export Restrictions Research Market & Funding Clinical Sequencing Growth
Revenue
$1.08B
▲ 0.4% YoY
Diluted EPS
$0.98
▼ 77.8% YoY
Gross margin
67.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2024-08-06
Illumina, Inc. Q2 FY2025 Earnings Call
Positive tone NovaSeq X transition and platform momentum Clinical market strength NovaSeq 6000 to X customer transition dynamics
Revenue
$1.06B
▼ 4.8% YoY
Diluted EPS
$1.49
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2024-05-02
Illumina, Inc. Q1 FY2025 Earnings Call
Balanced tone China export restrictions Guidance revision and ex-China targets NovaSeq X instrument placements
Revenue
$1.04B
▼ 3.3% YoY
Diluted EPS
$0.82
Gross margin
65.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q3
2024-02-08
Illumina, Inc. Q3 FY2024 Earnings Call
Positive tone Revenue and Regional Performance Operational Excellence and Margins Innovation Pipeline
Revenue
$1.08B
▼ 3.5% YoY
Diluted EPS
$4.42
Gross margin
69.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-02-08
Illumina, Inc. Q4 FY2024 Earnings Call
Positive tone NovaSeq X transition and pull-through China regulatory situation R&D investment strategy
Revenue
$1.10B*
▼ 1.6% YoY
Gross margin
65.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q2
2023-08-09
Illumina, Inc. Q2 FY2024 Earnings Call
Revenue
$1.11B
▼ 5.4% YoY
Diluted EPS
$-12.48
Gross margin
64.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-04-25
Illumina, Inc. Q4 FY2023 Earnings Call
Revenue
$1.12B*
▲ 3.5% YoY
Gross margin
60.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-02-07
Illumina, Inc. Q3 FY2023 Earnings Call
Revenue
$1.12B
▲ 0.4% YoY
Diluted EPS
$-4.77
Gross margin
61.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2022-08-11
Illumina, Inc. Q2 FY2023 Earnings Call
Revenue
$1.18B
▲ 1.2% YoY
Diluted EPS
$-1.48
Gross margin
62.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2022-05-05
Illumina, Inc. Q1 FY2023 Earnings Call
Revenue
$1.09B
▼ 11.1% YoY
Diluted EPS
$0.02
▼ 96.4% YoY
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q3
2022-02-10
Illumina, Inc. Q3 FY2022 Earnings Call
Revenue
$1.11B
▲ 0.6% YoY
Diluted EPS
$-23.60
▼ 1266.3% YoY
Gross margin
64.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-02-10
Illumina, Inc. Q4 FY2022 Earnings Call
Revenue
$1.08B*
▼ 9.6% YoY
Gross margin
62.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q2
2021-08-05
Illumina, Inc. Q2 FY2022 Earnings Call
Revenue
$1.16B
▲ 3.2% YoY
Diluted EPS
$-3.31
▼ 369.8% YoY
Gross margin
66.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2021-04-27
Illumina, Inc. Q4 FY2021 Earnings Call
Revenue
$1.20B*
▲ 25.8% YoY
Gross margin
68.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-02-11
Illumina, Inc. Q3 FY2021 Earnings Call
Revenue
$1.11B
▲ 39.5% YoY
Diluted EPS
$2.02
▲ 71.9% YoY
Gross margin
69.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2020-08-06
Illumina, Inc. Q2 FY2021 Earnings Call
Revenue
$1.13B
▲ 77.9% YoY
Diluted EPS
$1.23
▲ 293.7% YoY
Gross margin
71.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2020-04-30
Illumina, Inc. Q4 FY2020 Earnings Call
Revenue
$953.00M*
▲ 0% YoY
Gross margin
66.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q1
2020-04-30
Illumina, Inc. Q1 FY2021 Earnings Call
Revenue
$1.09B
▲ 27.2% YoY
Diluted EPS
$0.97
▼ 14.5% YoY
Gross margin
69.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q3
2020-01-29
Illumina, Inc. Q3 FY2020 Earnings Call
Revenue
$794.00M
▼ 12.5% YoY
Diluted EPS
$1.18
▼ 23.4% YoY
Gross margin
66.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2019-04-30
Illumina, Inc. Q1 FY2020 Earnings Call
Revenue
$859.00M
▲ 1.5% YoY
Diluted EPS
$1.14
▼ 25.5% YoY
Gross margin
72.1%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–26 of 26 earnings calls
Key facts CIK 1110803 CUSIP 452327109 13F (30d) 856 filings 826 filers Visit website Investor relations